GlassScriptPhysician profile
Aimee Bearden
NPI 1255881827
$1,765.65
in general payments reported to CMS, 2019-2025
17 companies · $484 in 2025
The $484 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $464 · 2023: $656 · 2024: $162 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $295.17 | 2022-2025 | Shingrix, Nucala, Benlysta |
| Medtronic, INC. | $276.67 | 2023-2025 | Linq II, Intellis Adaptivestim |
| Ipsen Biopharmaceuticals, INC | $132.52 | 2025 | Iqirvo |
| Janssen Pharmaceuticals, INC | $119.42 | 2022 | |
| Paratek Pharmaceuticals, INC. | $116.61 | 2022 | |
| Neurocrine Biosciences, INC. | $116.54 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.99 | 2023 | |
| Inspire Medical Systems, INC. | $80.95 | 2025 | Inspire |
| Nevro Corp. | $78.24 | 2024 | Senza |
| Axonics, INC. | $75.44 | 2023 | Axonics |
| E.R. Squibb & Sons, L.L.C. | $67.32 | 2022 | |
| Shield Therapeutics INC | $66.89 | 2023 | Accrufer |
| Biogen, INC. | $64.57 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.22 | 2024 | Lifevest |
| Ultragenyx Pharmaceutical INC. | $51.42 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $41.95 | 2022 | |
| Genzyme Corporation | $21.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Bearden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.